Key points are not available for this paper at this time.
UCAR T cells can overcome antigenic heterogeneity in GBM and lead to improved treatment outcomes.
Share your take
Add a clinician perspective alongside expert commentary.
Bielamowicz et al. (Fri,) studied this question.